Do maternally acquired antibodies protect infants from malaria infection?

Parasite Immunology

Volumn 23, Issue 2, 2001, Pages 51-59

  Riley, E M ^a,b   Wagner, G E ^b   Akanmori, B D ^c   Koram, K A ^c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c University of Ghana Legon   (Ghana)

Author keywords

Infant; Malaria; Materno foetal antibody transfer; Neonate

Indexed keywords

IMMUNOGLOBULIN G; MATERNAL ANTIBODY; PARASITE ANTIBODY;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; DISEASE SEVERITY; DISEASE TRANSMISSION; EPIDEMIOLOGICAL DATA; HUMAN; IMMUNE RESPONSE; INFANT; INFECTION RESISTANCE; INFECTION RISK; MALARIA; NEWBORN; NONHUMAN; OPSONIZATION; PARASITE IMMUNITY; PARASITEMIA; PASSIVE IMMUNIZATION; PLACENTAL TRANSFER; PLASMODIUM FALCIPARUM; PREVALENCE; PRIORITY JOURNAL; PROTECTION; REVIEW; RISK FACTOR; VERTICAL TRANSMISSION;

ANTIBODIES, PROTOZOAN; ANTIBODY FORMATION; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNITY, NATURAL; INFANT; INFANT, NEWBORN; MALARIA;

PLASMODIUM FALCIPARUM;

EID: 0035078699     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.2001.00364.x     Document Type: Review

References (64)

1. The development and maintenance of immunity to malaria in highly endemic areas
2. An analysis of malaria parasite rates in infants: 40 Years after Macdonald
3. Malaria in African infants and children in Southern Nigeria
4. Risk of severe malaria among African infants: Direct evidence of clinical protection during early infancy
5. Clinical case definitions for malaria: Clinical malaria associated with very low parasite densities in African infants
6. The analysis of malaria parasite rates in infants
7. High incidence of asymptomatic malaria infections in a birth cohort of children under 1 year of age in Ghana, detected by multicopy gene polymerase chain reaction
8. Lack of association between maternal antibody and protection of African infants from malaria infection
9. Frequent and persistent asymptomatic Plasmodium falciparum infections in African infants characterised by multilocus genotyping
10. Transplacental passage of Plasmodium falciparum and seroevaluation of newborns in Northern Nigera
11. The serologic response to primary malaria infection in urban Ghanaian infants
12. Adult and cord blood gammaglobulin and immunity to malaria in Nigerians
13. Plasma immunoglobulin concentration in mothers and newborn children with special reference to placental malaria. Studies in The Gambia, Nigeria and Switzerland
14. Plasma immunoglobulin concentrations in an African (Gambian) community in relation to season, malaria and other infections and pregnancy
15. Human placental Fc receptors and the trapping of immune complexes
16. Relationships between maternal malaria and malarial immune responses in mothers and neonates
17. Seroepidemiological studies of malaria in pregnant women and newborns from coastal El Salvador
18. Malaria chemosuppression during pregnancy IV. Its effect on the newborn's passive malaria immunity
19. Immunoglobulin complex deposits in Plasmodium falciparum-infected placentas from Malawi and Papua New Guinea
20. Placental malaria I. Pathological classification
21. Reduced transfer of tetanus antibodies with placental malaria
22. Isotypic analysis, antigen specificity and inhibitory function of maternally transmitted Plasmodium falciparum-specific antibodies in Gabonese newborns
23. Isotypic analysis of maternally transmitted Plasmodium falciparum-specific antibodies in Cameroon, and relationship with risk of P. falciparum infection
24. Identification of anti-Plasmodium falciparum antibodies in human breast milk
25. A longitudinal study of sero-reacitvities to Plasmodium falciparum antigens in Nigerian infants during their first year of life
26. Biological activities of immunoglobulins of different classes and subclasses
27. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro but act in co-operation with monocytes
28. Function and heterogeneity of human Fc receptors for immunoglobulin G
29. Plasmodium falciparum malaria: Evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity
30. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): Increasing prevalence with age and association with clinical immunity to malaria
31. Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea
32. Antibodies against Plasmodium falciparum vaccine candidates in infants in an area of intense and perennial transmission: Relationships with clinical malaria and with entomological inoculation rates
33. A longitudinal study of malaria infection, morbidity and antibody titres in infants of a rural community in Ghana
34. A seroepidemiological study to evaluate the role of passive maternal immunity to malaria in infants
35. Lack of association between levels of transplacen-tally acquired Plasmodium falciparum-specific antibodies and age of onset of clinical malaria in infants in a malaria endemic area of Nigeria
36. A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1, 19 kilodalton domain of Plasmodium falciparum in pregnant women and infants: Associations with febrile illness, parasitaemia and anaemia
37. Relationship between maternally derived anti-Plasmodium falciparum antibodies and risk of infection and disease in infants living in an area of Liberia, West Africa in which malaria is highly endemic
38. Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection
39. Recognition of dominant T cell stimulating epitopes from the circumsporozoite protein of Plasmodium falciparum and relationship to malaria morbidity in Gambian children
40. Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria
41. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19kDa C-terminal fragment of the merozoite surface antigen, PfMSP1
42. Immune recognition of the malaria vaccine candidate antigen Pf155/RESA is associated with resistance to clinical disease: A prospective study in a malaria endemic region of West Africa
43. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen of Plasmodium falciparum are associated with reduced malaria morbidity
44. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies
45. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity
46. Effects of foetal haemoglobin on susceptibility of red cells to Plasmodium falciparum
47. Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism
48. Changes in the human A antigen of erythrocytes with the individual's age
49. Developmental change and genetic defect in the carbohydrate structure of band 3 glycoprotein of human erythrocyte membrane
50. Transforming gowth factor-beta (TGF-β) in human milk
51. TGFbeta production is inversely correlated with severity of murine malaria infection
52. Selective induction of FCγRIII on human monocytes by transforming growth factor-b
53. IgG subclass levels in infancy and childhood
54. Mannose-binding lectin: The pluripotent molecule of the innate immune system
55. Mannose binding protein gene mutations associated with unusual and severe infections in adults
56. Mannose binding protein is not associated with malaria, hepatitis B carriage not tuberculosis in Africans
57. Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria
58. Evidence for an age-dependent pyrogenic threshold of Plasmodium falciparum parasitemia in highly endmeic populations
59. Decreased anti-toxic activities among children with clinical episodes of malaria
60. Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens
61. Early cytokine induction by Plasmodium falciparum is not a classical endotoxin-like process
62. Is T cell priming required for initiation of pathology in malaria infections?